MedPath

Effect of Text Message Reminders on M-ISI Score After Prostate Surgery

Not Applicable
Not yet recruiting
Conditions
Incontinence, Urinary Stress
Prostate Cancer
Benign Prostate Hyperplasia
Registration Number
NCT07071207
Lead Sponsor
University of Rochester
Brief Summary

The purpose of this study is to compare post-prostatectomy incontinence via Michigan Incontinence Score Index in patients receiving daily text message reminders for pelvic floor exercises when compared to those not receiving text reminders.

Detailed Description

This trial will be comprised of prostate cancer patients who have undergone a radical prostatectomy and benign prostate hyperplasia patients who have undergone a laser enucleation of the prostate. These two cohorts will each be split into an intervention and a control group. The purpose of this study is to evaluate post-prostatectomy incontinence via patient reported outcomes utilizing Michigan Incontinence Score Index in patients receiving daily text message reminders for pelvic floor exercises + standard of care (intervention group) compared to those receiving standard of care only (control group).

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
Male
Target Recruitment
132
Inclusion Criteria
  1. Planning to undergo a radical prostatectomy (RALP) or laser enucleation of the prostate (LEP) procedure
  2. Patient of URMC Urology
  3. Adult male 18 years of age and older
  4. Able to read, write, and speak in English (NOTE: due to limitations with questionnaire validation, only English-speaking subjects are permitted)
  5. Has access to a mobile device capable of receiving automated text messages.
  6. Willing to receive text messages and to complete questionnaires via SMS text.
  7. Willingness to participate and able to provide informed consent.
Exclusion Criteria
  1. Less than 18 years of age
  2. Unable to send and receive SMS texts
  3. Unable to read, write, and speak English
  4. Catheter dependency
  5. Has or plans to have Artificial Urinary Sphincter or Urethral Sling during the study period
  6. In the opinion of the investigator, the subject has a history or current evidence of any condition, therapy, or laboratory abnormality that might confound the results of the study, interfere with the subject's participation for the full duration of the study, or is not in the best interest of the subject to participate.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Time to Recovery to ContinenceFrom baseline until the participant reaches two successive M-ISI Pad Use Subdomain Scores of ≤ 2, assessed up to 12 months

The time it takes for participants to recover continence, as defined by two successive M-ISI Pad Use Subdomain Scores of ≤ 2. The Pad Use Subdomain Score is determined by the sum of items Q7-8 from the M-ISI questionnaire, assessed as a time-to-event outcome.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

158 Sawgrass clinic; Suite 3100

🇺🇸

Rochester, New York, United States

158 Sawgrass clinic; Suite 3100
🇺🇸Rochester, New York, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.